Critical Care

official impact factor 4.60

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

The safety profile of drotrecogin alfa (activated)

Roberto Fumagalli* and Mariano A Mignini

Critical Care 2007, 11(Suppl 5):S6 doi:10.1186/cc6157

Accesses  

  • Last 30 days: 38 accesses
  • Last year: 431 accesses
  • All time: 3632 accesses

Cited by

BioMed Central: 2 citations

Review   Free Highly Accessed

Recombinant human activated protein C: current insights into its mechanism of action

Marcel Levi, Tom van der Poll Critical Care 2007, 11(Suppl 5):S3 (19 December 2007)

Introduction   Free Highly Accessed

Introduction: severe sepsis and drotrecogin alfa (activated)

Antonio Artigas, Claude D Martin Critical Care 2007, 11(Suppl 5):S1 (19 December 2007)